Back
Vanguard S&P Small-Cap 600 Growth Index Fund ETF Vs. Travere Therapeutics, Inc. Sector Stock Comparison
Buy
69
VIOG
Vanguard S&P Small-Cap 600 Growth Index Fund ETF
Last Price:
$125.00
Seasonality Move:
1.13%
Buy
80
TVTX
Travere Therapeutics, Inc.
Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
69
Vanguard S&P Small-Cap 600 Growth Index Fund ETF (VIOG)
is a Buy
Is Vanguard S&P Small-Cap 600 Growth Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Small-Cap 600 Growth Index Fund ETF [VIOG] share price is $125.00. The Score for VIOG is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
VIOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VIOG Stock Price Chart
What is Vanguard S&P Small-Cap 600 Growth Index Fund ETF's stock price today?
-
The Vanguard S&P Small-Cap 600 Growth Index Fund ETF share price today is $125.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VIOG is experiencing slight buying pressure.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $40.2800Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
VIOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 30.75 | Buy |
| Relative Strength Index (14 RSI): | 58.41 | Buy |
| Chaikin Money Flow: | 2028 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.18 - 125.62) | Buy |
| Bollinger Bands (100): | (118 - 123.54) | Buy |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.67 | Buy |
| Relative Strength Index (14 RSI): | 69.35 | Buy |
| Chaikin Money Flow: | 1508490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.0318 - 36.4718) | Buy |
| Bollinger Bands (100): | (20.7309 - 34.2909) | Buy |
VIOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.51 | Buy |
| 20-day SMA: | 123.85 | Buy |
| 50-day SMA: | 121.57 | Buy |
| 200-day SMA: | 115.18 | Buy |
| 8-day EMA: | 89.09 | Buy |
| 20-day EMA: | 48.98 | Buy |
| 50-day EMA: | 22.54 | Buy |
| 200-day EMA: | 6.06 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.7 | Buy |
| 20-day SMA: | 35.23 | Buy |
| 50-day SMA: | 33.43 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 28.52 | Buy |
| 20-day EMA: | 16.32 | Buy |
| 50-day EMA: | 7.67 | Buy |
| 200-day EMA: | 2.09 | Buy |
Vanguard S&P Small-Cap 600 Growth Index Fund ETF Earnings Growth & VIOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
Vanguard S&P Small-Cap 600 Growth Index Fund ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||